
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Breast Cancer Update
00:00
Do You See One Plus in ER Positive Breast Cancer Patients?
The FDA approved fam trust to the map. 60 year old postmanopausal woman who was diagnosed with de novo metastatic ER PR positive and her too negative breast cancer. I started her on Abemma cyclib and let's resolve. And unfortunately she progressed. Later I treated her with alpolicib and full vestrant. She had scans earlier this week, which actually showed evidence of progression.
Play episode from 29:33
Transcript


